A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma

Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive solid malignant tumors worldwide. Increasing investigations demonstrate that long non-coding RNAs (lncRNAs) expression is abnormally dysregulated in cancers. It is crucial to identify and predict the prognosis of...

Full description

Bibliographic Details
Main Authors: Chenhao Zhou, Shun Wang, Qiang Zhou, Jin Zhao, Xianghou Xia, Wanyong Chen, Yan Zheng, Min Xue, Feng Yang, Deliang Fu, Yirui Yin, Manar Atyah, Lunxiu Qin, Yue Zhao, Christiane Bruns, Huliang Jia, Ning Ren, Qiongzhu Dong
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Oncology
Subjects:
pancreatic ductal adenocarcinoma
lncRNA
signature
prognosis
overall survival
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01160/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01160/full

Similar Items